274 related articles for article (PubMed ID: 35973787)
1. Faecal microbiota transplantation with anti-inflammatory diet (FMT-AID) followed by anti-inflammatory diet alone is effective in inducing and maintaining remission over 1 year in mild to moderate ulcerative colitis: a randomised controlled trial.
Kedia S; Virmani S; K Vuyyuru S; Kumar P; Kante B; Sahu P; Kaushal K; Farooqui M; Singh M; Verma M; Bajaj A; Markandey M; Sachdeva K; Das P; Makharia GK; Ahuja V
Gut; 2022 Dec; 71(12):2401-2413. PubMed ID: 35973787
[TBL] [Abstract][Full Text] [Related]
2. Coconut Water Induces Clinical Remission in Mild to Moderate Ulcerative Colitis: Double-blind Placebo-controlled Trial.
Kedia S; Virmani S; Bajaj A; Markandey M; Singh N; Madan D; Kaushal K; Sahu P; Vuyyuru SK; Kante B; Kumar P; Thomas DM; Mundhra SK; Singh MK; Verma M; Sharma R; Das P; Dash NR; Monga N; Awasthi A; Makharia G; Ahuja V
Clin Gastroenterol Hepatol; 2024 Jun; 22(6):1295-1306.e7. PubMed ID: 38278200
[TBL] [Abstract][Full Text] [Related]
3. Lyophilised oral faecal microbiota transplantation for ulcerative colitis (LOTUS): a randomised, double-blind, placebo-controlled trial.
Haifer C; Paramsothy S; Kaakoush NO; Saikal A; Ghaly S; Yang T; Luu LDW; Borody TJ; Leong RW
Lancet Gastroenterol Hepatol; 2022 Feb; 7(2):141-151. PubMed ID: 34863330
[TBL] [Abstract][Full Text] [Related]
4. Multidonor intensive faecal microbiota transplantation for active ulcerative colitis: a randomised placebo-controlled trial.
Paramsothy S; Kamm MA; Kaakoush NO; Walsh AJ; van den Bogaerde J; Samuel D; Leong RWL; Connor S; Ng W; Paramsothy R; Xuan W; Lin E; Mitchell HM; Borody TJ
Lancet; 2017 Mar; 389(10075):1218-1228. PubMed ID: 28214091
[TBL] [Abstract][Full Text] [Related]
5. Effect of Fecal Microbiota Transplantation on 8-Week Remission in Patients With Ulcerative Colitis: A Randomized Clinical Trial.
Costello SP; Hughes PA; Waters O; Bryant RV; Vincent AD; Blatchford P; Katsikeros R; Makanyanga J; Campaniello MA; Mavrangelos C; Rosewarne CP; Bickley C; Peters C; Schoeman MN; Conlon MA; Roberts-Thomson IC; Andrews JM
JAMA; 2019 Jan; 321(2):156-164. PubMed ID: 30644982
[TBL] [Abstract][Full Text] [Related]
6. Multidonor FMT capsules improve symptoms and decrease fecal calprotectin in ulcerative colitis patients while treated - an open-label pilot study.
Cold F; Browne PD; Günther S; Halkjaer SI; Petersen AM; Al-Gibouri Z; Hansen LH; Christensen AH
Scand J Gastroenterol; 2019 Mar; 54(3):289-296. PubMed ID: 30946615
[No Abstract] [Full Text] [Related]
7. Specific Bacteria and Metabolites Associated With Response to Fecal Microbiota Transplantation in Patients With Ulcerative Colitis.
Paramsothy S; Nielsen S; Kamm MA; Deshpande NP; Faith JJ; Clemente JC; Paramsothy R; Walsh AJ; van den Bogaerde J; Samuel D; Leong RWL; Connor S; Ng W; Lin E; Borody TJ; Wilkins MR; Colombel JF; Mitchell HM; Kaakoush NO
Gastroenterology; 2019 Apr; 156(5):1440-1454.e2. PubMed ID: 30529583
[TBL] [Abstract][Full Text] [Related]
8. Efficacy of Fecal Microbiota Transplantation in the Treatment of Active Ulcerative Colitis: A Systematic Review and Meta-Analysis of Double-Blind Randomized Controlled Trials.
El Hage Chehade N; Ghoneim S; Shah S; Chahine A; Mourad FH; Francis FF; Binion DG; Farraye FA; Hashash JG
Inflamm Bowel Dis; 2023 May; 29(5):808-817. PubMed ID: 35766805
[TBL] [Abstract][Full Text] [Related]
9. Recurrence of moderate to severe ulcerative colitis after fecal microbiota transplantation treatment and the efficacy of re-FMT: a case series.
Dang XF; Qing-Xi Wang ; Yin Z; Sun L; Yang WH
BMC Gastroenterol; 2020 Nov; 20(1):401. PubMed ID: 33243141
[TBL] [Abstract][Full Text] [Related]
10. Role of Faecal Microbiota Transplantation for Maintenance of Remission in Patients With Ulcerative Colitis: A Pilot Study.
Sood A; Mahajan R; Singh A; Midha V; Mehta V; Narang V; Singh T; Singh Pannu A
J Crohns Colitis; 2019 Sep; 13(10):1311-1317. PubMed ID: 30873549
[TBL] [Abstract][Full Text] [Related]
11. Use of Faecal Transplantation with a Novel Diet for Mild to Moderate Active Ulcerative Colitis: The CRAFT UC Randomised Controlled Trial.
Sarbagili Shabat C; Scaldaferri F; Zittan E; Hirsch A; Mentella MC; Musca T; Cohen NA; Ron Y; Fliss Isakov N; Pfeffer J; Yaakov M; Fanali C; Turchini L; Masucci L; Quaranta G; Kolonimos N; Godneva A; Weinberger A; Kopylov U; Levine A; Maharshak N
J Crohns Colitis; 2022 Mar; 16(3):369-378. PubMed ID: 34514495
[TBL] [Abstract][Full Text] [Related]
12. Fecal Microbiota Transplantation Induces Remission in Patients With Active Ulcerative Colitis in a Randomized Controlled Trial.
Moayyedi P; Surette MG; Kim PT; Libertucci J; Wolfe M; Onischi C; Armstrong D; Marshall JK; Kassam Z; Reinisch W; Lee CH
Gastroenterology; 2015 Jul; 149(1):102-109.e6. PubMed ID: 25857665
[TBL] [Abstract][Full Text] [Related]
13. STOP-Colitis pilot trial protocol: a prospective, open-label, randomised pilot study to assess two possible routes of faecal microbiota transplant delivery in patients with ulcerative colitis.
Quraishi MNN; Yalchin M; Blackwell C; Segal J; Sharma N; Hawkey P; McCune V; Hart AL; Gaya D; Ives NJ; Magill L; Loi S; Hewitt C; Gerasimidis K; Loman NJ; Hansen R; McMullan C; Mathers J; Quince C; Crees N; Iqbal T
BMJ Open; 2019 Nov; 9(11):e030659. PubMed ID: 31719078
[TBL] [Abstract][Full Text] [Related]
14. Fecal microbiota transplantation versus glucocorticoids for the induction of remission in mild to moderate ulcerative colitis.
Huang C; Huang Z; Ding L; Fu Y; Fan J; Mei Q; Lou L; Wang J; Yin N; Lu Y; Guo S; Zeng Y
J Transl Med; 2022 Aug; 20(1):354. PubMed ID: 35962454
[TBL] [Abstract][Full Text] [Related]
15. Findings From a Randomized Controlled Trial of Fecal Transplantation for Patients With Ulcerative Colitis.
Rossen NG; Fuentes S; van der Spek MJ; Tijssen JG; Hartman JH; Duflou A; Löwenberg M; van den Brink GR; Mathus-Vliegen EM; de Vos WM; Zoetendal EG; D'Haens GR; Ponsioen CY
Gastroenterology; 2015 Jul; 149(1):110-118.e4. PubMed ID: 25836986
[TBL] [Abstract][Full Text] [Related]
16. Protocol for faecal microbiota transplantation in ulcerative colitis (FMTUC): a randomised feasibility study.
Jitsumura M; Cunningham AL; Hitchings MD; Islam S; Davies AP; Row PE; Riddell AD; Kinross J; Wilkinson TS; Jenkins GJ; Williams JG; Harris DA
BMJ Open; 2018 Oct; 8(10):e021987. PubMed ID: 30341117
[TBL] [Abstract][Full Text] [Related]
17. Daily, oral FMT for long-term maintenance therapy in ulcerative colitis: results of a single-center, prospective, randomized pilot study.
Crothers JW; Chu ND; Nguyen LTT; Phillips M; Collins C; Fortner K; Del Rio-Guerra R; Lavoie B; Callas P; Velez M; Cohn A; Elliott RJ; Wong WF; Vo E; Wilcox R; Smith M; Kassam Z; Budd R; Alm EJ; Mawe GM; Moses PL
BMC Gastroenterol; 2021 Jul; 21(1):281. PubMed ID: 34238227
[TBL] [Abstract][Full Text] [Related]
18. Fecal microbiota transplantation for the maintenance of remission in patients with ulcerative colitis: A randomized controlled trial.
Lahtinen P; Jalanka J; Mattila E; Tillonen J; Bergman P; Satokari R; Arkkila P
World J Gastroenterol; 2023 May; 29(17):2666-2678. PubMed ID: 37213403
[TBL] [Abstract][Full Text] [Related]
19. Capsulized Fecal Microbiota Transplantation Induces Remission in Patients with Ulcerative Colitis by Gut Microbial Colonization and Metabolite Regulation.
Chen Q; Fan Y; Zhang B; Yan C; Zhang Q; Ke Y; Chen Z; Wang L; Shi H; Hu Y; Huang Q; Su J; Xie C; Zhang X; Zhou L; Ren J; Xu H
Microbiol Spectr; 2023 Jun; 11(3):e0415222. PubMed ID: 37093057
[TBL] [Abstract][Full Text] [Related]
20. Efficacy and safety of fecal microbiota transplantation for treating patients with ulcerative colitis: A systematic review and meta-analysis.
Zhao HL; Chen SZ; Xu HM; Zhou YL; He J; Huang HL; Xu J; Nie YQ
J Dig Dis; 2020 Oct; 21(10):534-548. PubMed ID: 33439534
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
